Multimodal Imaging in Pachychoroid Neovasculopathy: A Case Report [PDF]
Türk Oftalmoloji Dergisi, 2018 Pachychoroid neovasculopathy (PNV) is a form of type 1 neovascularization characterized by dilated choroidal vessels in areas of increased choroidal thickness. In this article, we describe a patient diagnosed with PNV.
Özlem Biçer +3 more
doaj +8 more sources
Choroidal caverns in pachychoroid neovasculopathy [PDF]
Acta Biomedica Scientifica, 2021 Background. Choroid plays an important role in the pathogenesis of retinal pathology. Choroidal cavern, a recently identifi ed fi nding of optical coherent tomography (OCT), has been described in some degenerative and atrophic forms of retinal pathology.
E. K. Pedanova
doaj +4 more sources
Pachychoroid neovasculopathy in extramacular choroidal neovascularization
Clinical Ophthalmology, 2016 Mrinali Patel Gupta, Irene Rusu, Carly Seidman, Anton Orlin, Donald J D’Amico, Szilard Kiss Department of Ophthalmology, Weill Cornell Medicine, New York-Presbyterian Hospital, New York, NY, USA Purpose: To review a series of extramacular ...
Gupta MP +5 more
doaj +6 more sources
Choroidal caverns in pachychoroid neovasculopathy [PDF]
Indian Journal of Ophthalmology, 2020 Apoorva Ayachit +3 more
doaj +4 more sources
Vanishing pachy-choroid in pachychoroid neovasculopathy under long-term anti-vascular endothelial growth factor therapy [PDF]
BMC Ophthalmology, 2021 Background To investigate the diagnostic value of choroidal thickness in the definition of pachychoroid neovasculopathy (PNV), especially in eyes treated with anti-vascular endothelial growth factor (VEGF) therapy.
Benedikt Schworm +6 more
doaj +3 more sources
A Comparative Study of Short-Term Vascular and Stromal Alterations of the Choroid Following Half-Fluence Photodynamic Therapy in Pachychoroid Neovasculopathy and Chronic Central Serous Chorioretinopathy [PDF]
Life, 2022 Background: Central serous chorioretinopathy (CSCR) and pachychoroid neovasculopathy (PNV) are among the pachychoroid spectrum diseases (PSDs). Half-fluence photodynamic therapy (hf-PDT) is one of the effective treatment methods for both diseases.
Özge Yanık +3 more
doaj +3 more sources
Photodynamic therapy combined with anti-vascular endothelial growth factor therapy for pachychoroid neovasculopathy. [PDF]
PLoS ONE, 2021 This multicenter retrospective study was conducted to evaluate the 1-year treatment outcome of photodynamic therapy (PDT) combined with anti-vascular endothelial growth factor (VEGF) therapy for pachychoroid neovasculopathy (PNV).
Akiko Miki +7 more
doaj +4 more sources
Efficacy of aflibercept combined with 80% dose photodynamic therapy for pachychoroid neovasculopathy [PDF]
Scientific ReportsTo evaluate the short-term treatment outcomes of 80% dose photodynamic therapy (PDT) combined with intravitreal aflibercept injection (IVA) for symptomatic pachychoroid neovasculopathy (PNV) in a working-age population.
Norihiko Nakagawa +3 more
doaj +4 more sources
Pachychoroid Spectrum Disorders: An Updated Review [PDF]
Journal of Ophthalmic & Vision Research, 2023 Pachychoroid disease spectrum is a recent term that has been associated with an increasing number of phenotypes. This review discusses updated findings for each of the typical pachychoroid entities (central serous chorioretinopathy, pachychoroid pigment ...
Richard B. Brown +2 more
doaj +2 more sources
Intravitreal Brolucizumab for Pachychoroid Neovasculopathy Associated With Chronic Central Serous Chorioretinopathy. [PDF]
Transl Vis Sci Technol, 2023 To evaluate the anatomical and functional outcomes of intravitreal brolucizumab in eyes with chronic central serous chorioretinopathy complicated by pachychoroid neovasculopathy.Retrospective analysis of 34 eyes treated with intravitreal brolucizumab.
Carosielli M +11 more
europepmc +6 more sources